Skip to content

The effect of exercise training on cognitive function and olfactory function

An open-label, before-and-after trial study as a test of the effects of exercise on cognitive function and olfactory function and their association - An open-label, before-and-after trial study as a test of the effects of exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049147
Enrollment
30
Registered
2022-10-11
Start date
2022-10-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

They participates in the exercise training three times a week and orally ingests the test food for 24 weeks.

Sponsors

Miura Clinic, Medical Corporation Kanonkai
Lead Sponsor
Curves Japan Co., Ltd
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1)Healthy women over the age of 65 (2)Subjects with a BMI of less than 25 at the time of informed consent (3)Subjects who had no exercise habit (do not continuously do aerobic exercise and strength training) (4)Subject who can come to the place on the day of the designated examination and undergo the examination (5)Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.

Exclusion criteria

Exclusion criteria: (1)Subjects who have had an allergic reaction to a fragrance in the past (2)Subjects who are allergic to milk or soy (3)Subjects who are allergic to food and drugs (4)Subjects who are undergoingdiet therapy and exercise therapy under the supervision of a doctor. (5)Subjects who have been instructed by a doctor to limit protein or exercise (6)Subjects with current or history of serious illness (7)Subjects who have a serious chronic disease and are taking regular medicines (8)Mental illness, diabetes, cranial nerve disease, heart disease (cardiac disease), depression, epilepsy or those who have a history of it (9)Subjects with severe anemia (10)Subjects with systolic blood pressure of 180 mmHg or higher and diastolic blood pressure of 100 mmHg or higher (11)Subjects who have difficulty walking or exercising independently (12)Subjects who have unintentionally lost 4.5kg or 5% or more in the last year (13)Subjects diagnosed with an olfactory disorder with a definite cause (14)Subjects who are judged to be unsuitable as a subject based on the results of MMSE (15)Subjects with severe hay fever or allergic rhinitis (including seasonal and perennial) symptoms (subjects who develop allergic symptoms during the test period and take steroids) (16)Subjects who routinely consume health foods that may affect test results (17)Subject who plan to travel abroad during the examination period (18)Subjects who are currently participating in studies involving the use of other foods or pharmaceuticals, studies in which cosmetics or pharmaceuticals are applied, those who have participated in other clinical studies within one month of obtaining informed consent, or who are willing to participate. (19)Current smoker (20)Subjects whose daily alcohol consumption exceeds an average of 60 g/day of pure alcohol equivalent. (21)Subjects who have been judged by the principal investigator or sub-investigator to be inappropriate for this study, in addition to the reasons listed above.

Design outcomes

Primary

MeasureTime frame
Mini Mental State Examination (MMSE) olfactory score

Secondary

MeasureTime frame
Questionnaires Raven's Colored Progressive Matrices (RCPM) Weight/body mass index Blood pressure

Countries

Japan

Contacts

Public ContactMakoto Terashima

Oneness Support Co., Ltd. Clinical Trial Division

mterashima@oneness-sup.co.jp06-4801-8917

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026